A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes
Abstract Background Both hypertension and dyslipidemia are considered as major modifiable risk factors of cardiovascular diseases (CVDs), and their prevalence in Egypt has increased in recent years. Evidence-based systematic evaluation of data on hypertension and dyslipidemia is critical for effecti...
Main Authors: | Ashraf Reda, Hany Ragy, Kanwal Saeed, Mohammed Ashraf Alhussaini |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-12-01
|
Series: | Journal of the Egyptian Public Health Association |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42506-021-00096-9 |
Similar Items
-
Patient journey for hypertension and dyslipidemia in Saudi Arabia: highlighting the evidence gaps
by: Ashraf Amir, et al.
Published: (2023-07-01) -
Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
by: Ashraf Reda, et al.
Published: (2020-05-01) -
Prevalence of Dyslipidemia among Korean Adults: Korea National Health and Nutrition Survey 1998-2005
by: Myung Ha Lee, et al.
Published: (2012-02-01) -
Dyslipidemia Prevalence among Tinnitus Patients of a Referral ENT Clinic in Tehran, Iran, 2018
by: Kourosh Etemadi, et al.
Published: (2019-06-01) -
Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010
by: Eun Roh, et al.
Published: (2013-12-01)